

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.26151585 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.26151585 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.95234209 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.40109998 |
| 5 | cell adhesion mediated by integrin (GO:0033627) | 5.04775222 |
| 6 | * COPII vesicle coating (GO:0048208) | 4.89914472 |
| 7 | endodermal cell differentiation (GO:0035987) | 4.87537487 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.65091643 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.65091643 |
| 10 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.54113550 |
| 11 | chondrocyte proliferation (GO:0035988) | 4.43378237 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 4.43251887 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.43251887 |
| 14 | intestinal cholesterol absorption (GO:0030299) | 4.37609450 |
| 15 | protein carboxylation (GO:0018214) | 4.31788243 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31788243 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.25247294 |
| 18 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.22908187 |
| 19 | positive regulation of nuclease activity (GO:0032075) | 4.00875155 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 3.94723927 |
| 21 | wound healing, spreading of epidermal cells (GO:0035313) | 3.89848396 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.83473522 |
| 23 | exocrine pancreas development (GO:0031017) | 3.81017330 |
| 24 | 4-hydroxyproline metabolic process (GO:0019471) | 3.80113480 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 3.76317305 |
| 26 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.72245807 |
| 27 | regulation of fibrinolysis (GO:0051917) | 3.64194701 |
| 28 | complement activation, alternative pathway (GO:0006957) | 3.60892204 |
| 29 | regulation of nuclease activity (GO:0032069) | 3.60395856 |
| 30 | cellular response to unfolded protein (GO:0034620) | 3.60360106 |
| 31 | collagen metabolic process (GO:0032963) | 3.59975479 |
| 32 | homocysteine metabolic process (GO:0050667) | 3.53664702 |
| 33 | regulation of protein activation cascade (GO:2000257) | 3.53447159 |
| 34 | intestinal absorption (GO:0050892) | 3.50587998 |
| 35 | ER-nucleus signaling pathway (GO:0006984) | 3.48234237 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.47480277 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 3.45742507 |
| 38 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.44383394 |
| 39 | regulation of cholesterol homeostasis (GO:2000188) | 3.41339624 |
| 40 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.39840642 |
| 41 | cellular response to topologically incorrect protein (GO:0035967) | 3.39502467 |
| 42 | collagen catabolic process (GO:0030574) | 3.39425088 |
| 43 | regulation of complement activation (GO:0030449) | 3.38995681 |
| 44 | blood vessel maturation (GO:0001955) | 3.37575135 |
| 45 | virion attachment to host cell (GO:0019062) | 3.37326928 |
| 46 | adhesion of symbiont to host cell (GO:0044650) | 3.37326928 |
| 47 | basement membrane organization (GO:0071711) | 3.36300644 |
| 48 | cell migration involved in heart development (GO:0060973) | 3.35809738 |
| 49 | multicellular organismal metabolic process (GO:0044236) | 3.35078623 |
| 50 | substrate-dependent cell migration (GO:0006929) | 3.33245953 |
| 51 | cellular response to vitamin (GO:0071295) | 3.30811576 |
| 52 | multicellular organismal catabolic process (GO:0044243) | 3.30153605 |
| 53 | * vesicle coating (GO:0006901) | 3.29473293 |
| 54 | chondrocyte development (GO:0002063) | 3.25638980 |
| 55 | high-density lipoprotein particle remodeling (GO:0034375) | 3.24850452 |
| 56 | extracellular matrix disassembly (GO:0022617) | 3.23485244 |
| 57 | cysteine metabolic process (GO:0006534) | 3.22238406 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.22103050 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.22103050 |
| 60 | endocrine pancreas development (GO:0031018) | 3.20174904 |
| 61 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.19021199 |
| 62 | regulation of extracellular matrix disassembly (GO:0010715) | 3.19002709 |
| 63 | kynurenine metabolic process (GO:0070189) | 3.18320131 |
| 64 | signal peptide processing (GO:0006465) | 3.17778505 |
| 65 | lipoprotein metabolic process (GO:0042157) | 3.16547596 |
| 66 | hypotonic response (GO:0006971) | 3.16392628 |
| 67 | peptide hormone processing (GO:0016486) | 3.16325263 |
| 68 | hyaluronan catabolic process (GO:0030214) | 3.15717319 |
| 69 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.14516298 |
| 70 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.13870885 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 3.13840962 |
| 72 | glyoxylate metabolic process (GO:0046487) | 3.12927134 |
| 73 | lysine metabolic process (GO:0006553) | 3.12429326 |
| 74 | lysine catabolic process (GO:0006554) | 3.12429326 |
| 75 | bone trabecula formation (GO:0060346) | 3.12080768 |
| 76 | sequestering of metal ion (GO:0051238) | 3.10650518 |
| 77 | collagen fibril organization (GO:0030199) | 3.10601527 |
| 78 | bile acid biosynthetic process (GO:0006699) | 3.09574367 |
| 79 | urea metabolic process (GO:0019627) | 3.07047799 |
| 80 | urea cycle (GO:0000050) | 3.07047799 |
| 81 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.06357979 |
| 82 | reverse cholesterol transport (GO:0043691) | 3.06185963 |
| 83 | response to endoplasmic reticulum stress (GO:0034976) | 3.05574484 |
| 84 | protein localization to endosome (GO:0036010) | 3.05247615 |
| 85 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.04213826 |
| 86 | tryptophan metabolic process (GO:0006568) | 3.03570645 |
| 87 | plasma lipoprotein particle clearance (GO:0034381) | 3.03376591 |
| 88 | epoxygenase P450 pathway (GO:0019373) | 3.02889567 |
| 89 | adhesion of symbiont to host (GO:0044406) | 3.02025461 |
| 90 | wound healing, spreading of cells (GO:0044319) | 3.01634469 |
| 91 | keratan sulfate catabolic process (GO:0042340) | 3.01416967 |
| 92 | skin morphogenesis (GO:0043589) | 3.01006963 |
| 93 | tryptophan catabolic process (GO:0006569) | 3.00766066 |
| 94 | indole-containing compound catabolic process (GO:0042436) | 3.00766066 |
| 95 | indolalkylamine catabolic process (GO:0046218) | 3.00766066 |
| 96 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.98111449 |
| 97 | low-density lipoprotein particle clearance (GO:0034383) | 2.97893583 |
| 98 | endocardial cushion development (GO:0003197) | 2.96147325 |
| 99 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.94714535 |
| 100 | cell-substrate junction assembly (GO:0007044) | 2.93945317 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93920721 |
| 102 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.93753491 |
| 103 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.92827691 |
| 104 | regulation of plasminogen activation (GO:0010755) | 2.91284571 |
| 105 | extracellular fibril organization (GO:0043206) | 2.90666971 |
| 106 | tyrosine metabolic process (GO:0006570) | 2.89909577 |
| 107 | positive regulation of glycolytic process (GO:0045821) | 2.89585263 |
| 108 | fibrinolysis (GO:0042730) | 2.89487684 |
| 109 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.89407113 |
| 110 | negative regulation of fatty acid transport (GO:2000192) | 2.89071052 |
| 111 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.89063666 |
| 112 | apoptotic cell clearance (GO:0043277) | 2.88575847 |
| 113 | hormone catabolic process (GO:0042447) | 2.87427775 |
| 114 | kidney mesenchyme development (GO:0072074) | 2.87353961 |
| 115 | protein maturation by protein folding (GO:0022417) | 2.86928894 |
| 116 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.86074914 |
| 117 | smooth muscle tissue development (GO:0048745) | 2.85937025 |
| 118 | cellular modified amino acid catabolic process (GO:0042219) | 2.85894460 |
| 119 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.85605166 |
| 120 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.83751612 |
| 121 | fibril organization (GO:0097435) | 2.82512225 |
| 122 | extracellular matrix assembly (GO:0085029) | 2.82354787 |
| 123 | response to unfolded protein (GO:0006986) | 2.82307978 |
| 124 | endothelial cell morphogenesis (GO:0001886) | 2.81996793 |
| 125 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.81518829 |
| 126 | cellular response to vitamin D (GO:0071305) | 2.81366408 |
| 127 | valine metabolic process (GO:0006573) | 2.81084769 |
| 128 | positive regulation of fatty acid oxidation (GO:0046321) | 2.80793490 |
| 129 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.80764926 |
| 130 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.79081187 |
| 131 | protein-lipid complex remodeling (GO:0034368) | 2.78968013 |
| 132 | macromolecular complex remodeling (GO:0034367) | 2.78968013 |
| 133 | plasma lipoprotein particle remodeling (GO:0034369) | 2.78968013 |
| 134 | bile acid metabolic process (GO:0008206) | 2.78846672 |
| 135 | bile acid and bile salt transport (GO:0015721) | 2.78233952 |
| 136 | nitrogen cycle metabolic process (GO:0071941) | 2.78028573 |
| 137 | phospholipid efflux (GO:0033700) | 2.77402805 |
| 138 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.75860054 |
| 139 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.75484082 |
| 140 | extracellular regulation of signal transduction (GO:1900115) | 2.74855386 |
| 141 | extracellular negative regulation of signal transduction (GO:1900116) | 2.74855386 |
| 142 | hemidesmosome assembly (GO:0031581) | 2.74257869 |
| 143 | cellular glucuronidation (GO:0052695) | 2.73574114 |
| 144 | stress fiber assembly (GO:0043149) | 2.73092219 |
| 145 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72186042 |
| 146 | response to topologically incorrect protein (GO:0035966) | 2.71724008 |
| 147 | peptidyl-proline hydroxylation (GO:0019511) | 2.71601705 |
| 148 | protein heterotrimerization (GO:0070208) | 2.70346932 |
| 149 | positive regulation of extracellular matrix organization (GO:1903055) | 2.70202083 |
| 150 | positive regulation of lipid catabolic process (GO:0050996) | 2.69562009 |
| 151 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.69167260 |
| 152 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.69017504 |
| 153 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.68523177 |
| 154 | ER overload response (GO:0006983) | 2.67822696 |
| 155 | coenzyme catabolic process (GO:0009109) | 2.67318081 |
| 156 | glomerular basement membrane development (GO:0032836) | 2.67192907 |
| 157 | positive regulation of osteoblast proliferation (GO:0033690) | 2.67036671 |
| 158 | aromatic amino acid family metabolic process (GO:0009072) | 2.66470085 |
| 159 | mesodermal cell differentiation (GO:0048333) | 2.63985078 |
| 160 | extracellular matrix organization (GO:0030198) | 2.63976681 |
| 161 | extracellular structure organization (GO:0043062) | 2.63015263 |
| 162 | type B pancreatic cell proliferation (GO:0044342) | 2.61354212 |
| 163 | protein hydroxylation (GO:0018126) | 2.60392068 |
| 164 | membrane raft organization (GO:0031579) | 2.60197441 |
| 165 | pinocytosis (GO:0006907) | 2.60136246 |
| 166 | cholesterol efflux (GO:0033344) | 2.59381591 |
| 167 | glomerular visceral epithelial cell development (GO:0072015) | 2.56529197 |
| 168 | sprouting angiogenesis (GO:0002040) | 2.55108003 |
| 169 | pericardium development (GO:0060039) | 2.53657769 |
| 170 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.52567366 |
| 171 | barbed-end actin filament capping (GO:0051016) | 2.49082193 |
| 172 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.47784813 |
| 173 | positive regulation of fibroblast migration (GO:0010763) | 2.47783763 |
| 174 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.47380909 |
| 175 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.45384550 |
| 176 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.45382992 |
| 177 | lymphangiogenesis (GO:0001946) | 2.45035081 |
| 178 | metanephric mesenchyme development (GO:0072075) | 2.44964856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.46608626 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.53967224 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.84563974 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.65674979 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.16560560 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.98084520 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.73462892 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64320463 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.47256624 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.42769955 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.30046723 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11869703 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.11816255 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.11356747 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.94590853 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.91450074 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.52948775 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43590504 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.29360467 |
| 20 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11054648 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98286703 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97596197 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95889640 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.95047011 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86669145 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.84315844 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81981374 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69417641 |
| 29 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.60370037 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59928093 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 1.56384489 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52840057 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52800833 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52359968 |
| 35 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51676217 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50556849 |
| 37 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.48363006 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.47008186 |
| 39 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46329768 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.43063183 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.42045041 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39101658 |
| 43 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38931737 |
| 44 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38931737 |
| 45 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.37196678 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34227663 |
| 47 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.32844264 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32794944 |
| 49 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32068397 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31046389 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29364225 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.26771085 |
| 53 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.26771085 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26267471 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23986742 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.19764729 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17792171 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16829830 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16531269 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16409403 |
| 61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16113188 |
| 62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15073084 |
| 63 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.13950926 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13388148 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13099784 |
| 66 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12329098 |
| 67 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.12071628 |
| 68 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11979311 |
| 69 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.11758551 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10945913 |
| 71 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.10933160 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10236661 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09509459 |
| 74 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.08723235 |
| 75 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06071268 |
| 76 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05019276 |
| 77 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04178475 |
| 78 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03548797 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03540167 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00840121 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00215401 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99926885 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99903100 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99708717 |
| 85 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99338298 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98513724 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98506071 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97882540 |
| 89 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97502261 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96256829 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95768303 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95203331 |
| 93 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95182186 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94958396 |
| 95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94615891 |
| 96 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94491175 |
| 97 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94296885 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94215060 |
| 99 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93108461 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93101574 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93101574 |
| 102 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92026273 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91899214 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90137568 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89584153 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88869557 |
| 107 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88563252 |
| 108 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88541084 |
| 109 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87987946 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87945902 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87870548 |
| 112 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87270646 |
| 113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86175858 |
| 114 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.84924791 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84280792 |
| 116 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84277904 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84238083 |
| 118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83975174 |
| 119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83705008 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76393506 |
| 121 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76221389 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73813473 |
| 123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73584191 |
| 124 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73413387 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72849514 |
| 126 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.72627705 |
| 127 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72156711 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.71812652 |
| 129 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71353041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.58409603 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.53394283 |
| 3 | MP0005360_urolithiasis | 4.06508979 |
| 4 | MP0005365_abnormal_bile_salt | 3.66371344 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.28076099 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.11098392 |
| 7 | MP0003252_abnormal_bile_duct | 2.92136513 |
| 8 | MP0005275_abnormal_skin_tensile | 2.81309479 |
| 9 | MP0003195_calcinosis | 2.72293371 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.57047287 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.54227950 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.40954935 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.37813997 |
| 14 | MP0006054_spinal_hemorrhage | 2.32559933 |
| 15 | MP0003283_abnormal_digestive_organ | 2.25177213 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17227590 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.15345856 |
| 18 | MP0003941_abnormal_skin_development | 2.11783055 |
| 19 | MP0005083_abnormal_biliary_tract | 2.10120962 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 2.10096127 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.98528174 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.98124380 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.93000123 |
| 24 | MP0009840_abnormal_foam_cell | 1.88613042 |
| 25 | MP0004272_abnormal_basement_membrane | 1.82324981 |
| 26 | MP0009384_cardiac_valve_regurgitation | 1.80915178 |
| 27 | MP0003279_aneurysm | 1.70569427 |
| 28 | MP0002896_abnormal_bone_mineralization | 1.63064862 |
| 29 | MP0001944_abnormal_pancreas_morphology | 1.56353605 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.55438925 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.53462425 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.53128072 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.51961079 |
| 34 | MP0002060_abnormal_skin_morphology | 1.45167927 |
| 35 | MP0005332_abnormal_amino_acid | 1.44500244 |
| 36 | MP0000609_abnormal_liver_physiology | 1.38108381 |
| 37 | MP0003868_abnormal_feces_composition | 1.36281828 |
| 38 | MP0002693_abnormal_pancreas_physiology | 1.33307001 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.32062568 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.30806455 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.29803170 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.29251057 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.27465657 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.24633104 |
| 45 | MP0005023_abnormal_wound_healing | 1.22610683 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 1.16686171 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.16329497 |
| 48 | MP0005164_abnormal_response_to | 1.15915121 |
| 49 | MP0001958_emphysema | 1.14268603 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.13514497 |
| 51 | MP0004134_abnormal_chest_morphology | 1.13019350 |
| 52 | MP0003448_altered_tumor_morphology | 1.12531971 |
| 53 | MP0004043_abnormal_pH_regulation | 1.11811964 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.09995522 |
| 55 | MP0005508_abnormal_skeleton_morphology | 1.08170736 |
| 56 | MP0000462_abnormal_digestive_system | 1.07392032 |
| 57 | MP0001849_ear_inflammation | 1.05946545 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.05777353 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.05208356 |
| 60 | MP0002928_abnormal_bile_duct | 1.02994091 |
| 61 | MP0001243_abnormal_dermal_layer | 1.01011055 |
| 62 | MP0001879_abnormal_lymphatic_vessel | 1.00775935 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.00237327 |
| 64 | MP0001915_intracranial_hemorrhage | 0.97335500 |
| 65 | MP0001542_abnormal_bone_strength | 0.96779325 |
| 66 | MP0003183_abnormal_peptide_metabolism | 0.96153060 |
| 67 | MP0009250_abnormal_appendicular_skeleto | 0.95269498 |
| 68 | MP0005595_abnormal_vascular_smooth | 0.94376633 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.94357903 |
| 70 | MP0000163_abnormal_cartilage_morphology | 0.91409146 |
| 71 | MP0001299_abnormal_eye_distance/ | 0.90672671 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 0.89917508 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.88055843 |
| 74 | MP0000678_abnormal_parathyroid_gland | 0.87023237 |
| 75 | MP0002168_other_aberrant_phenotype | 0.86758114 |
| 76 | MP0005375_adipose_tissue_phenotype | 0.86677073 |
| 77 | MP0009053_abnormal_anal_canal | 0.86449037 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.85853461 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.84482046 |
| 80 | MP0000598_abnormal_liver_morphology | 0.84416176 |
| 81 | MP0001756_abnormal_urination | 0.84256902 |
| 82 | MP0000534_abnormal_ureter_morphology | 0.83909314 |
| 83 | MP0003795_abnormal_bone_structure | 0.83335469 |
| 84 | MP0002933_joint_inflammation | 0.82548457 |
| 85 | MP0005408_hypopigmentation | 0.81731765 |
| 86 | MP0005390_skeleton_phenotype | 0.81141007 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.80664866 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.80583144 |
| 89 | MP0001614_abnormal_blood_vessel | 0.79740302 |
| 90 | MP0002108_abnormal_muscle_morphology | 0.78521382 |
| 91 | MP0003959_abnormal_lean_body | 0.78037551 |
| 92 | MP0002115_abnormal_skeleton_extremities | 0.77964206 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.77679850 |
| 94 | MP0002128_abnormal_blood_circulation | 0.77677067 |
| 95 | MP0005165_increased_susceptibility_to | 0.77665189 |
| 96 | MP0005451_abnormal_body_composition | 0.76169046 |
| 97 | MP0003828_pulmonary_edema | 0.74447480 |
| 98 | MP0008004_abnormal_stomach_pH | 0.69671545 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.69638916 |
| 100 | MP0005409_darkened_coat_color | 0.69027009 |
| 101 | MP0005197_abnormal_uvea_morphology | 0.68882566 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 0.68702067 |
| 103 | MP0000613_abnormal_salivary_gland | 0.68680253 |
| 104 | MP0004233_abnormal_muscle_weight | 0.67250972 |
| 105 | MP0003091_abnormal_cell_migration | 0.67044290 |
| 106 | MP0000733_abnormal_muscle_development | 0.67024157 |
| 107 | MP0005448_abnormal_energy_balance | 0.65651896 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.65618476 |
| 109 | MP0005621_abnormal_cell_physiology | 0.65336416 |
| 110 | MP0004858_abnormal_nervous_system | 0.64644391 |
| 111 | MP0002925_abnormal_cardiovascular_devel | 0.64508048 |
| 112 | MP0002254_reproductive_system_inflammat | 0.64222247 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.64188045 |
| 114 | MP0005670_abnormal_white_adipose | 0.64170110 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.64086566 |
| 116 | MP0003436_decreased_susceptibility_to | 0.63948660 |
| 117 | MP0003045_fibrosis | 0.63929078 |
| 118 | MP0001175_abnormal_lung_morphology | 0.63771431 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.63327807 |
| 120 | MP0006082_CNS_inflammation | 0.63040038 |
| 121 | MP0000428_abnormal_craniofacial_morphol | 0.62969559 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.62478026 |
| 123 | MP0005334_abnormal_fat_pad | 0.62223986 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.62075059 |
| 125 | MP0000432_abnormal_head_morphology | 0.61654232 |
| 126 | MP0001661_extended_life_span | 0.61640646 |
| 127 | MP0000858_altered_metastatic_potential | 0.60551351 |
| 128 | MP0009697_abnormal_copulation | 0.60381044 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.59522354 |
| 130 | MP0004883_abnormal_blood_vessel | 0.59410168 |
| 131 | MP0004130_abnormal_muscle_cell | 0.59005345 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.57540211 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.57316967 |
| 134 | MP0010307_abnormal_tumor_latency | 0.57078921 |
| 135 | MP0000249_abnormal_blood_vessel | 0.56555019 |
| 136 | MP0002133_abnormal_respiratory_system | 0.55366742 |
| 137 | MP0005388_respiratory_system_phenotype | 0.55366742 |
| 138 | MP0002113_abnormal_skeleton_development | 0.55351316 |
| 139 | MP0003942_abnormal_urinary_system | 0.55239920 |
| 140 | MP0000343_altered_response_to | 0.55171160 |
| 141 | MP0002971_abnormal_brown_adipose | 0.53572460 |
| 142 | MP0001881_abnormal_mammary_gland | 0.53381363 |
| 143 | MP0003385_abnormal_body_wall | 0.50813110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.04918260 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.85812865 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.58597108 |
| 4 | Hypoglycemic seizures (HP:0002173) | 4.41590181 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.28916989 |
| 6 | Vascular tortuosity (HP:0004948) | 4.25643878 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.07506003 |
| 8 | Follicular hyperkeratosis (HP:0007502) | 4.06501940 |
| 9 | Abnormality of the intrinsic pathway (HP:0010989) | 3.99079990 |
| 10 | Arterial tortuosity (HP:0005116) | 3.94723354 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.93727835 |
| 12 | Deep venous thrombosis (HP:0002625) | 3.88415821 |
| 13 | Xanthomatosis (HP:0000991) | 3.86228227 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.75824711 |
| 15 | Spondylolisthesis (HP:0003302) | 3.71236914 |
| 16 | Symptomatic seizures (HP:0011145) | 3.54300685 |
| 17 | Genu recurvatum (HP:0002816) | 3.52280145 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44509356 |
| 19 | Hyperglycemia (HP:0003074) | 3.38735878 |
| 20 | Ketoacidosis (HP:0001993) | 3.34091189 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.14439527 |
| 22 | Complement deficiency (HP:0004431) | 3.06991513 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.03512372 |
| 24 | Ketosis (HP:0001946) | 3.02428315 |
| 25 | Peritonitis (HP:0002586) | 3.01989017 |
| 26 | Cervical subluxation (HP:0003308) | 2.99723937 |
| 27 | Skin nodule (HP:0200036) | 2.85834466 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.84725252 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.84725252 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 2.81600888 |
| 31 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.76775908 |
| 32 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.76775908 |
| 33 | Late onset (HP:0003584) | 2.73652253 |
| 34 | Hyperextensible skin (HP:0000974) | 2.71428174 |
| 35 | Atrophic scars (HP:0001075) | 2.71409519 |
| 36 | Slender build (HP:0001533) | 2.71062377 |
| 37 | Aortic dissection (HP:0002647) | 2.69948201 |
| 38 | Bowel diverticulosis (HP:0005222) | 2.69858858 |
| 39 | Overgrowth (HP:0001548) | 2.68639984 |
| 40 | Fat malabsorption (HP:0002630) | 2.67813883 |
| 41 | Joint laxity (HP:0001388) | 2.64012220 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63407100 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 2.62992074 |
| 44 | Hypolipoproteinemia (HP:0010981) | 2.59925387 |
| 45 | Ankle contracture (HP:0006466) | 2.57074210 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.53472887 |
| 47 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.51617696 |
| 48 | Protuberant abdomen (HP:0001538) | 2.48912748 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.48474450 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48474450 |
| 51 | Epidermoid cyst (HP:0200040) | 2.41952018 |
| 52 | Abnormality of complement system (HP:0005339) | 2.41442923 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.40153849 |
| 54 | Thoracolumbar scoliosis (HP:0002944) | 2.37610462 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.37519562 |
| 56 | Myocardial infarction (HP:0001658) | 2.36244418 |
| 57 | Soft skin (HP:0000977) | 2.34926242 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.34654197 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.34392255 |
| 60 | Blue sclerae (HP:0000592) | 2.33913078 |
| 61 | Elbow flexion contracture (HP:0002987) | 2.32910625 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30730136 |
| 63 | Biconcave vertebral bodies (HP:0004586) | 2.30096292 |
| 64 | Cupped ribs (HP:0000887) | 2.28786508 |
| 65 | Nonimmune hydrops fetalis (HP:0001790) | 2.28184547 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.26469486 |
| 67 | Aortic regurgitation (HP:0001659) | 2.25599939 |
| 68 | Aneurysm (HP:0002617) | 2.23072931 |
| 69 | Beaking of vertebral bodies (HP:0004568) | 2.22442373 |
| 70 | Aortic aneurysm (HP:0004942) | 2.21783149 |
| 71 | Insulin resistance (HP:0000855) | 2.20977035 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20406414 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20406414 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20406414 |
| 75 | Ovoid vertebral bodies (HP:0003300) | 2.19820495 |
| 76 | Mitral stenosis (HP:0001718) | 2.18664647 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.18422248 |
| 78 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.17187231 |
| 79 | Right ventricular cardiomyopathy (HP:0011663) | 2.16960758 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.16252596 |
| 81 | Hydroxyprolinuria (HP:0003080) | 2.16252596 |
| 82 | Abdominal distention (HP:0003270) | 2.15544222 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.14545394 |
| 84 | Wormian bones (HP:0002645) | 2.13411769 |
| 85 | Ectopia lentis (HP:0001083) | 2.13053466 |
| 86 | Disproportionate tall stature (HP:0001519) | 2.12940554 |
| 87 | Abnormal tarsal ossification (HP:0008369) | 2.12273723 |
| 88 | Mitral valve prolapse (HP:0001634) | 2.11201843 |
| 89 | Abnormal foot bone ossification (HP:0010675) | 2.10956187 |
| 90 | Aortic valve stenosis (HP:0001650) | 2.10742820 |
| 91 | Fragile skin (HP:0001030) | 2.09013354 |
| 92 | Broad metatarsal (HP:0001783) | 2.07086584 |
| 93 | Joint hemorrhage (HP:0005261) | 2.06984664 |
| 94 | Abnormal cartilage morphology (HP:0002763) | 2.06204908 |
| 95 | Dilatation of the ascending aorta (HP:0005111) | 2.05458576 |
| 96 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.04242209 |
| 97 | Mild short stature (HP:0003502) | 2.03741238 |
| 98 | Dysostosis multiplex (HP:0000943) | 2.03498918 |
| 99 | Abnormality of the ischium (HP:0003174) | 2.02648133 |
| 100 | Wide anterior fontanel (HP:0000260) | 2.01486482 |
| 101 | Syringomyelia (HP:0003396) | 2.00877573 |
| 102 | Spinal cord lesions (HP:0100561) | 2.00877573 |
| 103 | Bladder diverticulum (HP:0000015) | 2.00616617 |
| 104 | Abnormality of dentin (HP:0010299) | 2.00606329 |
| 105 | Hyperammonemia (HP:0001987) | 1.99443743 |
| 106 | Hypoplastic ischia (HP:0003175) | 1.98827097 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 1.98088315 |
| 108 | Osteoarthritis (HP:0002758) | 1.96701277 |
| 109 | Vascular calcification (HP:0004934) | 1.95599479 |
| 110 | Back pain (HP:0003418) | 1.95582590 |
| 111 | Increased connective tissue (HP:0009025) | 1.95507129 |
| 112 | Mitral regurgitation (HP:0001653) | 1.95476755 |
| 113 | Increased variability in muscle fiber diameter (HP:0003557) | 1.94994355 |
| 114 | Short nail (HP:0001799) | 1.94650482 |
| 115 | Shallow orbits (HP:0000586) | 1.93621365 |
| 116 | Joint stiffness (HP:0001387) | 1.93464926 |
| 117 | Abnormal delivery (HP:0001787) | 1.93367797 |
| 118 | Hepatocellular carcinoma (HP:0001402) | 1.92905174 |
| 119 | Broad ribs (HP:0000885) | 1.92879918 |
| 120 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92773679 |
| 121 | Platyspondyly (HP:0000926) | 1.91660829 |
| 122 | Cardiovascular calcification (HP:0011915) | 1.91097799 |
| 123 | Thin bony cortex (HP:0002753) | 1.90971357 |
| 124 | Inguinal hernia (HP:0000023) | 1.90821092 |
| 125 | Natal tooth (HP:0000695) | 1.90672233 |
| 126 | Neonatal short-limb short stature (HP:0008921) | 1.89830597 |
| 127 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88788789 |
| 128 | Hypoventilation (HP:0002791) | 1.88096045 |
| 129 | Spinal rigidity (HP:0003306) | 1.88059925 |
| 130 | Persistence of primary teeth (HP:0006335) | 1.87801736 |
| 131 | Wrist flexion contracture (HP:0001239) | 1.87657785 |
| 132 | Long toe (HP:0010511) | 1.87272370 |
| 133 | Abnormality of the acetabulum (HP:0003170) | 1.85077028 |
| 134 | Breech presentation (HP:0001623) | 1.84830943 |
| 135 | Mesomelia (HP:0003027) | 1.84535421 |
| 136 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84236664 |
| 137 | Abnormality of skull ossification (HP:0002703) | 1.83720289 |
| 138 | Coxa vara (HP:0002812) | 1.83065001 |
| 139 | Tetraparesis (HP:0002273) | 1.82128261 |
| 140 | Camptodactyly of toe (HP:0001836) | 1.81489225 |
| 141 | Absent frontal sinuses (HP:0002688) | 1.80454486 |
| 142 | Femoral bowing (HP:0002980) | 1.79071285 |
| 143 | Chondrocalcinosis (HP:0000934) | 1.75059518 |
| 144 | Abnormality of carpal bone ossification (HP:0006257) | 1.74908040 |
| 145 | Protruding ear (HP:0000411) | 1.74056961 |
| 146 | Relative macrocephaly (HP:0004482) | 1.71608318 |
| 147 | Round ear (HP:0100830) | 1.71065110 |
| 148 | Renal duplication (HP:0000075) | 1.70105543 |
| 149 | Osteopenia (HP:0000938) | 1.69777370 |
| 150 | Flat cornea (HP:0007720) | 1.69019047 |
| 151 | Asymmetry of the thorax (HP:0001555) | 1.68335586 |
| 152 | Pectus carinatum (HP:0000768) | 1.68116678 |
| 153 | Ulnar bowing (HP:0003031) | 1.67924750 |
| 154 | Abnormality of Sharpey fibers (HP:0100685) | 1.67351676 |
| 155 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.65968078 |
| 156 | Striae distensae (HP:0001065) | 1.65416425 |
| 157 | Delayed cranial suture closure (HP:0000270) | 1.64410814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.18761649 |
| 2 | INSRR | 3.68512081 |
| 3 | TRIB3 | 3.47716109 |
| 4 | FRK | 3.18041303 |
| 5 | SIK1 | 2.84571136 |
| 6 | LATS1 | 2.70756925 |
| 7 | BCKDK | 2.65162501 |
| 8 | TAOK3 | 2.63752758 |
| 9 | MAPK15 | 2.52466450 |
| 10 | FLT3 | 2.51828636 |
| 11 | PDGFRA | 2.48328031 |
| 12 | PASK | 2.21442219 |
| 13 | DDR2 | 2.21172752 |
| 14 | PKN2 | 2.18580216 |
| 15 | EPHA3 | 2.09908639 |
| 16 | PTK6 | 2.04035592 |
| 17 | FGFR4 | 1.95512968 |
| 18 | CDK12 | 1.94810899 |
| 19 | TTN | 1.90253978 |
| 20 | MET | 1.72446988 |
| 21 | PIK3CG | 1.72365500 |
| 22 | PTK2 | 1.64223954 |
| 23 | MAP3K3 | 1.61152524 |
| 24 | RIPK1 | 1.54534636 |
| 25 | MAP3K2 | 1.38855781 |
| 26 | STK38 | 1.28485243 |
| 27 | EPHB1 | 1.26776302 |
| 28 | MST1R | 1.25453279 |
| 29 | SCYL2 | 1.22098313 |
| 30 | ACVR1B | 1.21236057 |
| 31 | FER | 1.19965937 |
| 32 | TIE1 | 1.18861058 |
| 33 | PAK3 | 1.16635952 |
| 34 | LIMK1 | 1.13562039 |
| 35 | HIPK2 | 1.12538059 |
| 36 | NEK9 | 1.11083073 |
| 37 | KIT | 1.08643499 |
| 38 | NTRK1 | 1.07646667 |
| 39 | PTK2B | 1.07048516 |
| 40 | MAP3K14 | 1.06609361 |
| 41 | PAK2 | 1.05433843 |
| 42 | PRKD3 | 1.03588488 |
| 43 | MAP3K10 | 1.01206006 |
| 44 | ERBB4 | 0.99427255 |
| 45 | EPHA2 | 0.99185445 |
| 46 | CAMK1G | 0.97545595 |
| 47 | MELK | 0.97112403 |
| 48 | WNK1 | 0.96956425 |
| 49 | JAK1 | 0.94469655 |
| 50 | STK38L | 0.91610254 |
| 51 | NUAK1 | 0.89745241 |
| 52 | MTOR | 0.87201900 |
| 53 | STK3 | 0.85910179 |
| 54 | JAK3 | 0.84466443 |
| 55 | CLK1 | 0.83060542 |
| 56 | LATS2 | 0.81546597 |
| 57 | DYRK1B | 0.81508656 |
| 58 | MAP2K2 | 0.79443444 |
| 59 | BRSK2 | 0.78678344 |
| 60 | MAP3K1 | 0.77780269 |
| 61 | IRAK3 | 0.76361579 |
| 62 | TESK1 | 0.74216665 |
| 63 | PIK3CA | 0.73129392 |
| 64 | MAPK7 | 0.72669100 |
| 65 | PDGFRB | 0.72455364 |
| 66 | STK24 | 0.72389639 |
| 67 | PRPF4B | 0.71631228 |
| 68 | KSR2 | 0.70668294 |
| 69 | CSK | 0.68029212 |
| 70 | ICK | 0.67962333 |
| 71 | PRKG2 | 0.67347162 |
| 72 | MAPKAPK3 | 0.67308962 |
| 73 | TYK2 | 0.65129507 |
| 74 | JAK2 | 0.64381081 |
| 75 | FGFR3 | 0.63956180 |
| 76 | ROCK2 | 0.62152725 |
| 77 | TRPM7 | 0.61905853 |
| 78 | CDC42BPA | 0.61426890 |
| 79 | MAP2K1 | 0.61295026 |
| 80 | TGFBR2 | 0.60857869 |
| 81 | KDR | 0.60556219 |
| 82 | PRKCH | 0.59961106 |
| 83 | EEF2K | 0.59370057 |
| 84 | MYLK | 0.57912709 |
| 85 | CAMK1D | 0.57683339 |
| 86 | BMX | 0.56985821 |
| 87 | RET | 0.56556016 |
| 88 | PRKD2 | 0.56281980 |
| 89 | WNK4 | 0.55149484 |
| 90 | LRRK2 | 0.55143772 |
| 91 | GRK7 | 0.54096911 |
| 92 | GSK3A | 0.54095765 |
| 93 | PRKD1 | 0.54007943 |
| 94 | RPS6KA4 | 0.53254044 |
| 95 | TBK1 | 0.52879510 |
| 96 | STK10 | 0.52784842 |
| 97 | MAP3K12 | 0.51685767 |
| 98 | MAP3K8 | 0.50746635 |
| 99 | MAPK11 | 0.50583863 |
| 100 | SMG1 | 0.50325098 |
| 101 | IRAK1 | 0.49240965 |
| 102 | AKT3 | 0.48543076 |
| 103 | TEC | 0.47669894 |
| 104 | TGFBR1 | 0.44721208 |
| 105 | DAPK3 | 0.44583266 |
| 106 | DMPK | 0.44549620 |
| 107 | MAP2K3 | 0.44381110 |
| 108 | IGF1R | 0.44338283 |
| 109 | PRKAA2 | 0.43978425 |
| 110 | MAP3K13 | 0.43946445 |
| 111 | ABL2 | 0.43314478 |
| 112 | EPHB2 | 0.41646304 |
| 113 | PRKAA1 | 0.40605572 |
| 114 | TAOK2 | 0.39694196 |
| 115 | ADRBK1 | 0.38808626 |
| 116 | PRKCE | 0.37961056 |
| 117 | CDK6 | 0.37535942 |
| 118 | SGK3 | 0.37401797 |
| 119 | NEK1 | 0.37104191 |
| 120 | EIF2AK3 | 0.36693383 |
| 121 | MAP3K6 | 0.35844558 |
| 122 | ZAP70 | 0.35589211 |
| 123 | FGFR1 | 0.35229860 |
| 124 | CHUK | 0.34339621 |
| 125 | NLK | 0.32923877 |
| 126 | INSR | 0.31500193 |
| 127 | ERBB2 | 0.30704301 |
| 128 | PRKCI | 0.28510324 |
| 129 | ROCK1 | 0.27670175 |
| 130 | RPS6KA2 | 0.26813360 |
| 131 | MOS | 0.25415153 |
| 132 | PAK4 | 0.24905362 |
| 133 | PRKACG | 0.23650585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.46769427 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.02080747 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.67855127 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.66762048 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.57915549 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54843951 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.47281377 |
| 8 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.31900323 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18685392 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17945796 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14526970 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.11503862 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01709525 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97765140 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.96930951 |
| 16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.88427053 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.79267254 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69315814 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.63717420 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63366840 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61795310 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58548368 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56219664 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.52231940 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50485732 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50456585 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50356416 |
| 28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.48907521 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47323807 |
| 30 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.40491259 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39504272 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.37668423 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35919852 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32856533 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28068900 |
| 36 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.26628499 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25093618 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24516762 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22283887 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.22025639 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15893038 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.15669766 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.13764423 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13679404 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10798967 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10150533 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09094730 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08583909 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.07947935 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05396272 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05200381 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04832285 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04237131 |
| 54 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.03877674 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03586227 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03456456 |
| 57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.03411628 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02314174 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01509406 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00894314 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 1.00882415 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00836307 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98889746 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96377896 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94918974 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91733224 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.91261285 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91257824 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.90752768 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.89640023 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87132658 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86345082 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86304517 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86042266 |
| 75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84779626 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.84445980 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83406539 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82058293 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80953135 |
| 80 | Pathways in cancer_Homo sapiens_hsa05200 | 0.78824674 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.77314555 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77297892 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.75270665 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.75158530 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72349124 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72014250 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.71435554 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.69854769 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69687617 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67886136 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.64986245 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64945754 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.64546837 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.63603405 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.63294822 |
| 96 | Measles_Homo sapiens_hsa05162 | 0.61956170 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61285487 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59716786 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59332023 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.58660287 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58374347 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57702472 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55775407 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53887311 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.52234199 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52068981 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51724650 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.50426826 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50219299 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50060815 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49958885 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49914671 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49459725 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49334829 |
| 115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48052189 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47831037 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47116190 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.46612186 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46256982 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.46094009 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45514710 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45387181 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44642951 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44348806 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42606932 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.42423804 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.41667113 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41545920 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40788768 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40646302 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40478006 |
| 132 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39954117 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39934787 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37628961 |
| 135 | Glioma_Homo sapiens_hsa05214 | 0.37611239 |
| 136 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37174467 |
| 137 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36205836 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35500284 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35350873 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35281591 |
| 141 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34413417 |
| 142 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34388784 |
| 143 | Apoptosis_Homo sapiens_hsa04210 | 0.34103397 |
| 144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33959738 |
| 145 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33474518 |
| 146 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33082925 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32134786 |
| 148 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28443118 |
| 149 | Legionellosis_Homo sapiens_hsa05134 | 0.28147959 |
| 150 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28028810 |
| 151 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26727065 |
| 152 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26332100 |
| 153 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.25283656 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23419738 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23305092 |
| 156 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22765943 |
| 157 | Prostate cancer_Homo sapiens_hsa05215 | 0.21562244 |
| 158 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20844333 |

